tiprankstipranks
Seres Therapeutics reports Q3 EPS 58c, consensus (24c)
PremiumThe FlySeres Therapeutics reports Q3 EPS 58c, consensus (24c)
8d ago
Seres Therapeutics expects cash to fund operations into Q4 of 2025
Premium
The Fly
Seres Therapeutics expects cash to fund operations into Q4 of 2025
8d ago
Seres Therapeutics Inc. (MCRB) Q3 Earnings Cheat Sheet
Premium
Pre-Earnings
Seres Therapeutics Inc. (MCRB) Q3 Earnings Cheat Sheet
17d ago
Seres shareholders request clarity from board about possible Nestle offer
PremiumThe FlySeres shareholders request clarity from board about possible Nestle offer
2M ago
Seres Therapeutics shareholders approve sale of VOWST
Premium
The Fly
Seres Therapeutics shareholders approve sale of VOWST
2M ago
Seres Therapeutics’ SER-155 Shows Promising Clinical Results
Premium
Company Announcements
Seres Therapeutics’ SER-155 Shows Promising Clinical Results
2M ago
Seres Therapeutics Unveils Updated Corporate Presentation
PremiumCompany AnnouncementsSeres Therapeutics Unveils Updated Corporate Presentation
3M ago
Seres Therapeutics sees cash runway into 4Q25 upon VOWST sale close
Premium
The Fly
Seres Therapeutics sees cash runway into 4Q25 upon VOWST sale close
3M ago
Seres Therapeutics reports Q2 EPS (22c), consensus (27c)
Premium
The Fly
Seres Therapeutics reports Q2 EPS (22c), consensus (27c)
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100